Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents

Danielle Hammond; Sanam Loghavi; Sa A. Wang; Marina Y. Konopleva; Tapan M. Kadia; Naval G. Daver; Maro Ohanian; Ghayas C. Issa; Yesid Alvarado; Nicholas J. Short; Koji Sasaki; Naveen Pemmaraju; Guillermo Montalban-Bravo; Curtis A. Lachowiez; Abhishek Maiti; Guillermo Garcia-Manero; Elias J. Jabbour; Gautam Borthakur; Farhad Ravandi; Koichi Takahashi; Sherry R. Pierce; Hagop M. Kantarjian; Courtney D. DiNardo

doi:10.1038/s41408-023-00915-6

Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents

Danielle Hammond, Sanam Loghavi, Sa A. Wang, Marina Y. Konopleva, Tapan M. Kadia, Naval G. Daver, Maro Ohanian, Ghayas C. Issa, Yesid Alvarado, Nicholas J. Short, Koji Sasaki, Naveen Pemmaraju, Guillermo Montalban-Bravo, Curtis A. Lachowiez, Abhishek Maiti, Guillermo Garcia-Manero, Elias J. Jabbour, Gautam Borthakur, Farhad Ravandi, Koichi TakahashiSherry R. Pierce, Hagop M. Kantarjian, Courtney D. DiNardo

Research output: Contribution to journal › Letter › peer-review

7 Scopus citations

Original language	English (US)
Article number	148
Journal	Blood cancer journal
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41408-023-00915-6
State	Published - Dec 2023

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1038/s41408-023-00915-6

Cite this

@article{8721cb2cbca94617a92b773c0a73b371,

title = "Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents",

author = "Danielle Hammond and Sanam Loghavi and Wang, {Sa A.} and Konopleva, {Marina Y.} and Kadia, {Tapan M.} and Daver, {Naval G.} and Maro Ohanian and Issa, {Ghayas C.} and Yesid Alvarado and Short, {Nicholas J.} and Koji Sasaki and Naveen Pemmaraju and Guillermo Montalban-Bravo and Lachowiez, {Curtis A.} and Abhishek Maiti and Guillermo Garcia-Manero and Jabbour, {Elias J.} and Gautam Borthakur and Farhad Ravandi and Koichi Takahashi and Pierce, {Sherry R.} and Kantarjian, {Hagop M.} and DiNardo, {Courtney D.}",

note = "Funding Information: This research is supported in part by the MD Anderson Cancer Center Leukemia SPORE CA10063 and the MD Anderson Cancer Center support grant P30 CA016672. CDD is the recipient of and is supported by the Lloyd Family/V Foundation Clinical Scholar Award and LLS Scholar in Clinical Research. ",

year = "2023",

month = dec,

doi = "10.1038/s41408-023-00915-6",

language = "English (US)",

volume = "13",

journal = "Blood cancer journal",

issn = "2044-5385",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents

AU - Hammond, Danielle

AU - Loghavi, Sanam

AU - Wang, Sa A.

AU - Konopleva, Marina Y.

AU - Kadia, Tapan M.

AU - Daver, Naval G.

AU - Ohanian, Maro

AU - Issa, Ghayas C.

AU - Alvarado, Yesid

AU - Short, Nicholas J.

AU - Sasaki, Koji

AU - Pemmaraju, Naveen

AU - Montalban-Bravo, Guillermo

AU - Lachowiez, Curtis A.

AU - Maiti, Abhishek

AU - Garcia-Manero, Guillermo

AU - Jabbour, Elias J.

AU - Borthakur, Gautam

AU - Ravandi, Farhad

AU - Takahashi, Koichi

AU - Pierce, Sherry R.

AU - Kantarjian, Hagop M.

AU - DiNardo, Courtney D.

N1 - Funding Information: This research is supported in part by the MD Anderson Cancer Center Leukemia SPORE CA10063 and the MD Anderson Cancer Center support grant P30 CA016672. CDD is the recipient of and is supported by the Lloyd Family/V Foundation Clinical Scholar Award and LLS Scholar in Clinical Research.

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85171896204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85171896204&partnerID=8YFLogxK

U2 - 10.1038/s41408-023-00915-6

DO - 10.1038/s41408-023-00915-6

M3 - Letter

C2 - 37735426

AN - SCOPUS:85171896204

SN - 2044-5385

VL - 13

JO - Blood cancer journal

JF - Blood cancer journal

IS - 1

M1 - 148

ER -

Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this